AstraZeneca and Amgen’s Tezspire (tezepelumab) has demonstrated significant improvements in tissue inflammation and ...

Diagnostic innovation and patient safety have dominated this year’s healthcare-focussed awards to mark European Laboratory ...

Private asset manager Capital Dynamics has invested €14m in Celsus Holding, the holding company through which private equity ...

Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal ...

A pilot scheme in east London is offering cholesterol-lowering injections at community pharmacies to help patients access ...

AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved by the European ...

Medtronic has received CE Mark approval for its Vitalis portfolio of five pacemakers, including a device designed for ...

Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence (AI) to investigate why ...

Private asset manager Capital Dynamics has invested €14m in Celsus Holding, the holding company through which private equity ...

Onicor, a medical technology company developing a personalised treatment for onychomycosis (fungal nail infection), has ...

The Scottish Medicines Consortium (SMC) has accepted AbbVie’s Aquipta (atogepant) as an option for the acute treatment of ...

Otologist and neurotologist Dr. Peter Weber has been appointed Chief Medical Officer of biotech Sensorion. The company, which ...